Provider review
Rivo Health review
Halves every price under a limited-time banner, and prints the standing rate beside it.
The pre-discount figure is shown rather than implied, so what the price reverts to is visible — the one thing a limited-time headline usually hides. What is not published is the date the reversion happens.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Rivo Health
$114/mo sema at half price, $228/mo standing
- Vs median
- $55/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every seller running a countdown prints the discounted number and leaves you to discover the other one later. This one prints both, side by side, across its injectable and oral options — semaglutide at half rate with the standing figure right beside it. That is how a promotion should be shown, and it is uncommon enough here to be the main reason to take the site seriously. The gap is the calendar. Nothing published says when the offer ends, so you can see the rate you will eventually pay without knowing when you start paying it, and on a treatment measured in months that is most of the budgeting question. Two smaller things. The savings advertised on longer supplies are calculated against the undiscounted rate rather than the one actually on offer, so they read considerably larger than the choice in front of you. And every injectable figure is a "starting at" with no dose published behind it — so the low number is a floor of unstated depth rather than the price of a small dose, which for anyone planning to hold low is the difference that matters.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see what the price reverts to before committing to a discounted rate.
- You want an oral option priced alongside the injectable rather than quoted separately.
- You want multi-month discounts applied automatically instead of hunting for a code.
Look elsewhere if
- You need to know when the discount ends. No date is published anywhere.
- You are pricing a low dose. Every figure is a starting point with no dose behind it.
- You take advertised savings at face value. They are quoted against the undiscounted rate.
What it actually costs
Price as published
Compounded semaglutide from $114/month against a standing $228, an oral option from $149 against $279 and a second oral from $199 against $389, each pair shown together under a "50% OFF NOW!" banner · ★ unusually, the pre-discount figure is printed rather than implied, so a reader can see what the price reverts to — which is the one thing a limited-time headline normally hides · nothing published says when the offer ends, so the standing rate is visible but its start date is not · savings are advertised against multi-month supplies ("SAVE $2,588", and smaller figures applied automatically at six and three months) · every injectable figure is prefixed "Starting at" with no dose behind it
- Vs median
- $55/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Semaglutide is priced at half rate with the standing figure printed beside it, so both numbers are readable before intake. Oral options are priced too. No low-dose product is sold, and every injectable figure is a "starting at" with no dose behind it, so the floor is not a low-dose rate — it is a floor of unstated depth inside a standard plan.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Prints the standing rate beside the discounted one, so what the price reverts to is visible.
- Publishes oral options with their own figures rather than injectables alone.
- Multi-month discounts are applied automatically rather than requiring a code.
Pharmacy, labs and oversight
Rivo Health dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Rivo Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Most sellers running a limited-time headline print the discounted figure and leave the reader to wonder what it reverts to. Rivo Health prints both. Semaglutide is half price against a standing figure shown right beside it, and the same pairing runs across its oral options. That is the honest way to run a promotion, and it is rare enough here to be the main reason to look. What is missing is the date. Nothing says when the offer ends, so a reader can see the rate they will eventually pay but not when they will start paying it — and on a treatment measured in months rather than weeks, that gap is the whole budgeting question. The savings figures attached to longer supplies are quoted against the undiscounted rate rather than the one a reader is being offered, so they read larger than the choice actually is. And every injectable price is a "starting at" with no dose published behind it, which means the low end of the range is a floor of unstated depth rather than the price of a low dose.
The honest cons
No end date is published for the discount, so when the standing rate begins is unknown.
- Savings figures are quoted against the undiscounted rate, which makes them read larger than the actual choice.
- Every injectable price is "starting at" with no dose published behind it.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Rivo Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#174 of 373
Ordered with the companies that pay us first, and Rivo Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Oral semaglutide (Rybelsus)
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.